Systemic Botulism Toxicity Caused by Pyloric Botox Injection to Treat Gastroparesis
Gordon P. Bensen, Cristina C. Rutherford, Timothy B. Gardner
Case Reports in Gastroenterology · 2020
doi:10.1159/000508854 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Systemic botulism resulting from therapeutic Botox (OnabotulinumtoxinA) injection has been rarely reported, and never in the context of pylorus injection to treat gastroparesis. We report the case of a 27-year-old female with Emery-Dreifuss muscular dystrophy who developed severe systemic botulism toxicity following the intrapyloric injection of 100 units of Botox to treat gastroparesis. The patient eventually made a full recovery.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.